European Archives - Page 795 of 1167 - European Medical Journal

Sexual Dysfunction: Quality of Life in Men with Prostate Cancer

SEXUAL DYSFUNCTION was one of the two major differences in quality of life (QoL) between men treated for advanced prostate cancer…

The Double Life of p53, the Guardian of the Genome

WIDELY understood as a suppressor of cancer development, earning it the nickname ‘the guardian of the genome’, the protein p53 may, in fact, also promote…

Metabolic Brain Age: Sex Differences Identified

OLDER women commonly outperform men in their age group in tests of reasoning, memory, and problem-solving, but the reason for this is currently unknown…

Low Coprococcus and Dialister Levels Linked with Depression

IS THERE a link between the gut and mental health? More specifically, is depression linked to gut bacteria? Scientists from Belgium set out to add another…

EMJ Dermatology 6 [Suppl 3] 2019

Prof Bieber opened the symposium by explaining that there has been a revolution in the management of patients with moderate-to-severe atopic dermatitis…

Translating Evidence to Practice: From Clinical Research to Real-World Experience

The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…

World Cancer Day Message: Cancer Awareness and Empowerment – Every citizen should act as an ambassador!

Whoever you are, you have the power to reduce the impact of cancer for yourself, the people you love, and for the world. It’s time to make a personal…

Response to Rituximab Cannot be Predicted by Smoking Status

RHEUMATOID ARTHRITIS (RA) is influenced by many factors, including alcohol consumption, smoking, and obesity. However, until recently no study had…

Improving Cardiovascular Outcomes for Rheumatoid Arthritis Patients

ATHEROSCLEROSIS rates were reduced in patients with rheumatoid arthritis as a result of adopting a treat-to-target approach compared with a traditional…

EMJ Dermatology 6 [Suppl 2] 2019

This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis. FAE, first developed in 1959 and approved in 1994..